Protara Therapeutics Cash Flow Statement (2013-2026) | TARA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-12.79M	-10.83M	-12.31M	-11.61M	-10.21M	-9.13M	-40.06M	-9.46M	-13.44M	-11.38M	-13.00M	-15.46M	-10.94M	-17.69M	-11.38M	-18.26M	-20.98M	-19.37M	-19.49M	-28.93M
Depreciation and Depletion (Quarter)	0.06M	-0.02M	0.05M	0.06M	0.05M	0.06M	0.07M	0.08M	0.08M	0.08M	0.11M	0.08M	0.08M	0.08M	0.08M	0.08M	0.10M	0.09M	0.09M	0.09M
Share-based Compensation (Quarter)	1.64M	1.41M	1.91M	1.56M	1.55M	1.15M	1.43M	0.31M	1.29M	1.45M	1.45M	1.07M	0.11M	0.82M	0.42M	0.12M	0.74M	0.85M	1.04M	11.64M
Cash from Operations (Quarter)	-9.47M	-6.20M	-6.91M	-10.96M	-5.12M	-5.35M	-5.03M	-12.89M	-9.41M	-6.56M	-8.70M	-10.38M	-7.69M	-8.43M	-9.31M	-14.71M	-12.25M	-12.45M	-16.95M	-21.34M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.46M	0.53M	0.46M	0.41M	0.35M	0.27M	0.11M	-0.07M	-0.13M	-0.13M	-0.11M	-0.07M	-0.01M	-0.33M	-0.28M	-0.17M	-0.37M	-0.40M	-0.32M	-0.19M
Amortization of Deferred Charges (Quarter)	0.35M	0.31M	0.34M	0.34M	0.34M	0.34M	0.34M	0.34M	0.34M	0.03M	0.30M	0.25M	0.25M	0.25M	0.26M	0.26M	0.27M	0.27M	0.28M	0.28M
Depreciation & Amortization (CF) (Quarter)	0.06M	-0.02M	0.05M	0.06M	0.05M	0.06M	0.07M	0.08M	0.08M	0.08M	0.11M	0.08M	0.08M	0.08M	0.08M	0.08M	0.10M	0.09M	0.09M	0.09M
Change in Working Capital
Change in Account Payables (Quarter)	-0.45M	-0.47M	0.03M	-0.41M	-0.15M	0.06M	1.13M	2.50M	-2.23M	0.65M	-0.07M	-1.46M	0.41M	0.91M	1.52M	-1.50M	2.99M	-0.80M	-1.56M	1.09M
Change in Accured Expenses (Quarter)	-0.42M	-0.23M	1.28M	-1.04M	0.77M	0.14M	-1.19M	-1.84M	0.73M	0.42M	0.18M	0.80M	-0.30M	2.04M	0.14M	-1.87M	-0.28M	0.92M	2.04M	-2.60M
Other Working Capital Changes (Quarter)												-0.24M	-0.24M	-0.25M	-0.25M	-0.26M	-0.28M	-0.29M	-0.30M	-0.30M
Investing Activities
Capital Expenditures (Quarter)	0.33M	-0.06M	0.04M	0.01M	0.02M	0.08M	0.01M	0.01M	0.00M	0.04M				0.01M		0.04M	0.02M	0.00M	0.02M
Sales of Property, Plant and Equipment (Quarter)
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)						19.13M	10.78M	22.05M	22.35M	6.42M	14.52M	23.10M	3.00M		22.50M	7.50M	4.00M	17.91M	35.82M	29.14M
Cash from Investing Activities (Quarter)	-1.94M	0.11M	1.89M	0.74M	13.50M	19.05M	-18.34M	9.86M	22.35M	6.38M	14.52M	23.10M	2.94M	-29.39M	22.50M	-58.35M	-47.72M	-6.51M	-26.91M	-14.72M
Financing Activities
Other financing activities (Quarter)																0.00M	0.01M	-0.01M	0.02M	1.94M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Short-Term Debt issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)	0.67M	0.33M	1.83M	1.98M			1.83M	2.97M	2.00M	0.16M	2.90M	0.05M	1.50M	3.83M	5.69M	4.91M	1.08M	5.64M	3.54M	1.19M
Net Equity Issued and Repurchased (Quarter)
Misc.
Cash from Financing Activities (Quarter)				-0.07M		-0.02M		-0.06M		-0.03M		-0.08M	42.09M		97.85M	1.73M	0.01M	0.01M	80.96M	1.14M
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)	-11.41M	-6.09M	-5.02M	-10.29M	8.38M	13.68M	-23.37M	-3.09M	12.94M	-0.21M	5.82M	12.64M	37.35M	-37.82M	111.04M	-71.34M	-59.97M	-18.95M	37.11M	-34.92M
Free Cash Flow (Quarter)	-9.80M	-6.14M	-6.95M	-10.97M	-5.14M	-5.43M	-5.03M	-12.89M	-9.41M	-6.60M	-8.70M	-10.38M	-7.69M	-8.44M	-9.31M	-14.76M	-12.27M	-12.46M	-16.97M	-21.34M
Net Cash Flow (Quarter)	-11.41M	-6.09M	-5.02M	-10.29M	8.38M	13.68M	-23.37M	-3.09M	12.94M	-0.21M	5.82M	12.64M	37.35M	-37.82M	111.04M	-71.34M	-59.97M	-18.95M	37.11M	-34.92M

Research Tools

Developers

Protara Therapeutics Cash Flow Statement (2013-2026) | TARA

Research Tools

Developers

Protara Therapeutics Cash Flow Statement (2013-2026) | TARA

Create an account

Sign In

Reset Password